Skip to main content

Table 1 List of significantly dysregulated RMPs identified using dysregulation score-based analysis

From: Integrative analyses of the RNA modification machinery reveal tissue- and cancer-specific signatures

Short name Cancer type Upregulated RMPs Downregulated RMPs
ACC Adrenocortical carcinoma BUD23, FBL, LAGE3, TRMT112, VIRMA ADAT2, APOBEC3G, TARBP1
BLCA Bladder urothelial carcinoma HENMT1 ADARB1
BRCA Breast invasive carcinoma LAGE3 TRMT9B
CESC Cervical squamous cell carcinoma and endocervical adenocarcinoma APOBEC3A, HENMT1
COAD Colon adenocarcinoma APOBEC1, DKC1, HENMT1 ADARB1
ESCA Esophageal carcinoma HENMT1, RBM15, ZC3H13 ADAD2, METTL17
GBM Glioblastoma multiforme APOBEC3G, HSD17B10 ADARB2, FBLL1, TARBP1
HNSC Head and neck squamous cell carcinoma HENMT1
KICH Kidney chromophobe ISCU
KIRC Kidney renal clear cell carcinoma APOBEC3G
KIRP Kidney renal papillary cell carcinoma METTL27
LAML Acute myeloid leukemia APOBEC3A, HENMT1
LGG Brain lower-grade glioma HSD17B10, TRMT5 ADARB1, HENMT1, TARBP1
LIHC Liver hepatocellular carcinoma LAGE3, METTL27, TARBP1 ADAT2, METTL17, NSUN6, TRMT11, ZC3H13
LUAD Lung adenocarcinoma LAGE3, METTL1, TFB2M ADARB1, APOBEC3A,TRMT9B
LUSC Lung squamous cell carcinoma DKC1, FBL, LAGE3, METTL1, METTL8 ADARB1, TRMT9B
OV Ovarian serous cystadenocarcinoma YTHDC2
PAAD Pancreatic adenocarcinoma APOBEC1, APOBEC3G, HENMT1 QTRT1, WDR6
PCPG Pheochromocytoma and paraganglioma FBLL1 MPST
PRAD Prostate adenocarcinoma APOBEC3G, METTL17
READ Rectum adenocarcinoma APOBEC1, DKC1, HENMT1 ADARB1
SARC Sarcoma HENMT1 ADARB1, ISCU, SERGEF
SKCM Skin cutaneous melanoma APOBEC3G
STAD Stomach adenocarcinoma HENMT1 METTL17,TRMT2A, WDR6
TGCT Testicular germ cell tumors EMG1, FBL, HNRNPC, HSD17B10, LAGE3, METTL9 ADAD1, ADAD2
THCA Thyroid carcinoma LAGE3, TRMT112 ADAT2, METTL17, TRMT9B, TRMU
UCEC Uterine corpus endometrial carcinoma LAGE3 ADARB1
UCS Uterine carcinosarcoma FBL, HENMT1, HSD17B10, LAGE3, TRMT112